Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Policies And Incentives For Promoting Innovation In Antibiotic Research
Download Policies And Incentives For Promoting Innovation In Antibiotic Research full books in PDF, epub, and Kindle. Read online Policies And Incentives For Promoting Innovation In Antibiotic Research ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Policies and Incentives for Promoting Innovation in Antibiotic Research by : WHO Regional Office for Europe
Download or read book Policies and Incentives for Promoting Innovation in Antibiotic Research written by WHO Regional Office for Europe and published by . This book was released on 2013-12-16 with total page 220 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Policies and Incentives for Promoting Innovation in Antibiotic Research by : Elias Mossialos
Download or read book Policies and Incentives for Promoting Innovation in Antibiotic Research written by Elias Mossialos and published by World Health Organization. This book was released on 2010 with total page 236 pages. Available in PDF, EPUB and Kindle. Book excerpt: High levels of pathogen resistance are rendering current antibiotics obsolete. Coupled with insufficient investment in discovering new treatments, multidrug-resistant infections are an increasingly urgent public health concern. To curb the growth of antibiotic resistance and prevent major morbidity and mortality from multidrug-resistant bacterial infections, the overuse of antibiotics must be addressed and research and development for antibiotics with novel mechanisms of action actively promoted. This requires appropriately designed incentives for health and regulatory systems, in addition to economic incentives to attract academic interest and industry investment. This book, commissioned by the Swedish Government from the European Observatory on Health Systems and Policies, analyzes many proposed policies and incentive mechanisms and sheds light on the key issues that will help policy-makers reach informed, concrete decisions on how to avert this potential public health crisis.
Book Synopsis How Can the EU Support Sustainable Innovation and Access to Effective Antibiotics? by : Michael Anderson (Research officer)
Download or read book How Can the EU Support Sustainable Innovation and Access to Effective Antibiotics? written by Michael Anderson (Research officer) and published by . This book was released on 2023 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Antimicrobial and particularly antibiotic resistance is one of the biggest public health challenges the world faces. Over 1 million years of life are lost each year in the European Union (EU)/European Economic Area (EEA) alone due to antibiotic resistance, and it costs healthcare systems about €1.1 billion annually. These health and economic impacts are expected to worsen. Urgent steps are needed and this policy brief focuses on one area where the EU and its Member States can take effective action, fostering sustainable innovation and improving access to effective antibiotics.1. Scientific, economic, structural and regulatory 'barriers' continue to limit the development of novel antibiotics with innovative characteristics despite intensified international efforts. 1.1. Only a handful of new antibiotics have been developed and launched over the last few decades, and almost none have any innovative characteristics. This means that they are vulnerable to cross-resistance with existing antibiotics.1.2. Most large pharmaceutical companies have withdrawn from antibiotic research and development (R&D) because of the high risk of failure and because antibiotics are less profitable than other areas.1.3. Small and medium-sized enterprises (SMEs), which now drive antibiotic R&D, face difficulty securing funding for preclinical and early clinical trials, and risk significant economic losses when launching new antibiotics.2. Reinvigorating the antibiotic pipeline requires a holistic package of incentives. 1.1. Push incentives, such as direct funding and grants, can reduce the cost of R&D and have already improved the quality of the preclinical pipeline to some extent.1.2. Pull incentives, such as financial rewards linked to R&D results, reimbursement reforms and regulatory changes, could increase potential revenue and create viable markets for antibiotics.1.3. Aligning incentives is important and can be achieved by addressing: - public health factors targeting high-priority medical need, supporting antibiotic sustainability, promoting access, and protecting environmental health- market factors improving return on investment and supporting SMEs- implementation and operational feasibility considering potential political, regulatory, legislative, industry and financial hurdles.3. Ensuring timely access to new and existing antibiotics is critical. 1.1. Limited access to effective antibiotics poses a risk to patients and drives the development of resistance.1.2. Access to new antibiotics is often restricted because they are only launched in larger markets.1.3. Access to many existing antibiotics is undermined by supply-chain problems or by their withdrawal due to low profitability.4. Improving access to effective antibiotics requires both short- and longer-term measures. 1.1. Reducing regulatory administrative hurdles, engaging in good procurement practice, increasing joint purchasing efforts, and considering subscription payment models for these medicines can keep older (but effective) antibiotics on the market by ensuring their economic viability.1.2. Strengthening the mapping of production capacities and product availability will improve the transparency of the antibiotic supply chain.1.3. Stockpiling and strengthening manufacturing capacities within and outside of the EU can boost the supply chain itself.5. The EU has a major role to play both in combatting antimicrobial resistance (AMR) and in contributing to global solutions. 1.1. The EU has a major role to play by supporting antibiotic R&D - increased and coordinated funding at the EU level can support both push and pull incentives.1.2. EU engagement with other international efforts promotes optimal deployment of incentives.1.3. EU commitment can help ensure that the lack of access to appropriate and effective antibiotics is recognized as a threat to global health security and a priority.1.4. The EU is uniquely placed to build on its relationships with international institutions and act as a facilitator in the global space, to ensure synergies among existing structures, communicate the cost of inaction, and support national and regional initiatives.
Book Synopsis Challenges to Tackling Antimicrobial Resistance by : Michael Anderson
Download or read book Challenges to Tackling Antimicrobial Resistance written by Michael Anderson and published by Cambridge University Press. This book was released on 2020-04-23 with total page 273 pages. Available in PDF, EPUB and Kindle. Book excerpt: An accessible overview of the challenges in tackling AMR, and the economic and policy responses of the 'One Health' approach. It will appeal to policy-makers seeking to strengthen national and local polices tackling AMR, as well as students and academics who want an overview of the latest scientific evidence regarding effective AMR policies.
Author :National Academies of Sciences, Engineering, and Medicine Publisher :National Academies Press ISBN 13 :0309498511 Total Pages :103 pages Book Rating :4.3/5 (94 download)
Book Synopsis The Role of NIH in Drug Development Innovation and Its Impact on Patient Access by : National Academies of Sciences, Engineering, and Medicine
Download or read book The Role of NIH in Drug Development Innovation and Its Impact on Patient Access written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2020-01-27 with total page 103 pages. Available in PDF, EPUB and Kindle. Book excerpt: To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Download or read book Antibiotics written by David M. Shlaes and published by Springer Science & Business Media. This book was released on 2010-09-02 with total page 108 pages. Available in PDF, EPUB and Kindle. Book excerpt: Antibiotics are truly miracle drugs. As a class, they are one of the only ones that actually cure disease as opposed to most drugs that only help relieve symptoms or control disease. Since bacteria that cause serious disease in humans are becoming more and more resistant to the antibiotics we have today, and because they will ultimately become resistant to any antibiotic that we use for treatment or for anything else, we need a steady supply of new antibiotics active against any resistant bacteria that arise. However, the antibiotics marketplace is no longer attractive for large pharmaceutical companies, the costs of development are skyrocketing because of ever more stringent requirements by the regulatory agencies, and finding new antibiotics active against resistant strains is getting harder and harder. These forces are all combining to deny us these miracle drugs when we need them the most. I provide a number of possible paths to shelter from this perfect storm.
Book Synopsis Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade by : World Intellectual Property Organization
Download or read book Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade written by World Intellectual Property Organization and published by WIPO. This book was released on 2013 with total page 259 pages. Available in PDF, EPUB and Kindle. Book excerpt: This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.
Book Synopsis Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine by : National Academies Of Sciences Engineeri
Download or read book Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine written by National Academies Of Sciences Engineeri and published by National Academies Press. This book was released on 2022-07-20 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: The National Strategy for Combating Antibiotic Resistant Bacteria, published in 2014, sets out a plan for government work to mitigate the emergence and spread of resistant bacteria. Direction on the implementation of this strategy is provided in five-year national action plans, the first covering 2015 to 2020, and the second covering 2020 to 2025. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine evaluates progress made against the national strategy. This report discusses ways to improve detection of resistant infections and estimate the risk to human health from environmental sources of resistance. In addition, the report considers the effect of agricultural practices on human and animal health and animal welfare and ways these practices could be improved, and advises on key drugs and diseases for which animal-specific test breakpoints are needed.
Author :Walter A. Garcia-Fontes Publisher :Springer Science & Business Media ISBN 13 :8493806277 Total Pages :105 pages Book Rating :4.4/5 (938 download)
Book Synopsis Incentives for Research, Development, and Innovation in Pharmaceuticals by : Walter A. Garcia-Fontes
Download or read book Incentives for Research, Development, and Innovation in Pharmaceuticals written by Walter A. Garcia-Fontes and published by Springer Science & Business Media. This book was released on 2012-01-12 with total page 105 pages. Available in PDF, EPUB and Kindle. Book excerpt: Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.
Book Synopsis Antibiotic Drug Discovery by : Steven M Firestine
Download or read book Antibiotic Drug Discovery written by Steven M Firestine and published by Royal Society of Chemistry. This book was released on 2017-05-19 with total page 289 pages. Available in PDF, EPUB and Kindle. Book excerpt: Recent years have seen a resurgence of antibiotic drug discovery. This book brings together the relevant information to assess the state-of-the-art. It identifies and elaborates the most recent and compelling strategies for antibiotic drug discovery with a primary focus on new targets, mechanisms and molecular entities. Addressing the need for continued investment in antibiotic drug development, the book provides a point of reference for the rapidly expanding infectious disease research community. In addition to its attention on new targets, the book focusses on the medicinal chemistry and chemistry of the targets. Within this framework, chapters from leading researchers in academia and industry address findings in important areas such as biofilm production, narrow spectrum antibiotics and novel antibacterials from previously uncultured soil bacteria. This book will be a useful resource for postgraduate students and researchers in medicinal chemistry wishing to understand the latest approaches to antibiotic drug discovery.
Book Synopsis Antimicrobial Resistance and Implications for the 21st Century by : I.W. Fong
Download or read book Antimicrobial Resistance and Implications for the 21st Century written by I.W. Fong and published by Springer Science & Business Media. This book was released on 2007-11-15 with total page 411 pages. Available in PDF, EPUB and Kindle. Book excerpt: This comprehensive, up-to-date volume defines the issues and offers potential solutions to the challenges of antimicrobial resistance. The chapter authors are leading international experts on antimicrobial resistance among a variety of bacteria, viruses including HIV and herpes, parasites and fungi. The chapters explore the molecular mechanisms of drug resistance, the immunology and epidemiology of resistance strains, clinical implications and implications on research and lack thereof, and prevention and future directions.
Book Synopsis Ethics and Drug Resistance: Collective Responsibility for Global Public Health by : Euzebiusz Jamrozik
Download or read book Ethics and Drug Resistance: Collective Responsibility for Global Public Health written by Euzebiusz Jamrozik and published by Springer. This book was released on 2021-08-21 with total page 448 pages. Available in PDF, EPUB and Kindle. Book excerpt: This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.
Book Synopsis Extending the Cure by : Ramanan Laxminarayan
Download or read book Extending the Cure written by Ramanan Laxminarayan and published by Routledge. This book was released on 2010-09-30 with total page 193 pages. Available in PDF, EPUB and Kindle. Book excerpt: Our ability to treat common bacterial infections with antibiotics goes back only 65 years. However, the authors of this report make it clear that sustaining a supply of effective and affordable antibiotics cannot be without changes to the incentives facing patients, physicians, hospitals, insurers, and pharmaceutical manufacturers. In fact, increasing resistance to these drugs is already exacting a terrible price. Every day in the United States, approximately 172 men, women, and children die from infections caused by antibiotic-resistant bacteria in hospitals alone. Beyond those deaths, antibiotic resistance is costing billions of dollars through prolonged hospital stays and the need for doctors to resort to ever more costly drugs to use as substitute treatments. Extending the Cure presents the problem of antibiotic resistance as a conflict between individual decision makers and their short-term interest and the interest of society as a whole, in both present and future: The effort that doctors make to please each patient by prescribing a drug when it might not be properly indicated, poor monitoring of discharged patients to ensure that they do not transmit drug-resistant pathogens to other persons, excesses in the marketing of new antibiotics, and the broad overuse of antibiotics all contribute to the development and spread of antibiotic-resistant bacteria. The book explores a range of policy options that would encourage patients, health care providers, and managed care organizations to serve as more responsible stewards of existing antibiotics as well as proposals that would give pharmaceutical firms greater incentives to develop new antibiotics and avoid overselling. If the problem continues unaddressed, antibiotic resistance has the potential to derail the health care system and return us to a world where people of all ages routinely die from simple infections. As a basis for future research and a spur to a critically important dialogue, Extending the Cure is a fundamental first step in addressing this public health crisis. The Extending the Cure project is funded in part by the Robert Wood Johnson Foundation through its Pioneer Portfolio.
Book Synopsis OECD Science, Technology and Industry Outlook 2012 by : OECD
Download or read book OECD Science, Technology and Industry Outlook 2012 written by OECD and published by OECD Publishing. This book was released on 2012-09-13 with total page 466 pages. Available in PDF, EPUB and Kindle. Book excerpt: Based on the latest information and indicators in science and innovation, the OECD Science, Technology and Industry Outlook 2012 reviews key trends in STI policies and performance in OECD countries and major emerging economies, and across a number of thematic areas.
Book Synopsis Antibiotic Resistance by : Institute of Medicine
Download or read book Antibiotic Resistance written by Institute of Medicine and published by National Academies Press. This book was released on 2011-01-10 with total page 496 pages. Available in PDF, EPUB and Kindle. Book excerpt: Years of using, misusing, and overusing antibiotics and other antimicrobial drugs has led to the emergence of multidrug-resistant 'superbugs.' The IOM's Forum on Microbial Threats held a public workshop April 6-7 to discuss the nature and sources of drug-resistant pathogens, the implications for global health, and the strategies to lessen the current and future impact of these superbugs.
Book Synopsis Technological Challenges in Antibiotic Discovery and Development by : National Research Council
Download or read book Technological Challenges in Antibiotic Discovery and Development written by National Research Council and published by National Academies Press. This book was released on 2014-01-27 with total page 82 pages. Available in PDF, EPUB and Kindle. Book excerpt: Technological Challenges in Antibiotic Discovery and Development is the summary of a workshop convened by the Chemical Sciences Roundtable in September 2013 to explore the current state of antibiotic discovery and examine the technology available to facilitate development. Through formal presentations and panel discussions, participants from academia, industry, federal research agencies discussed the technical challenges present and the incentives and disincentives industry faces in antibiotic development, and identified novel approaches to antibiotic discovery. Antibiotic resistance is a serious and growing problem in modern medicine and it is emerging as a pre-eminent public health threat. Each year in the United States alone, at least two million acquire serious infections with bacteria that are resistant to one or more antibiotics, and at least 23,000 people die annually as a direct result of these antibiotic-resistant infections. In addition to the toll on human life, antibiotic-resistant infections add considerable and avoidable costs to the already overburdened U.S. health care system. This report explores the challenges in overcoming antibiotic resistance, screening for new antibiotics, and delivering them to the sites of infection in the body. The report also discusses a path forward to develop the next generation of potent antimicrobial compounds capable of once again tilting the battle against microbial pathogens in favor of humans. Technological Challenges in Antibiotic Discovery and Development gives a broad view of the landscape of antibiotic development and the technological challenges and barriers to be overcome.
Book Synopsis OECD Health Policy Studies Pharmaceutical Innovation and Access to Medicines by : OECD
Download or read book OECD Health Policy Studies Pharmaceutical Innovation and Access to Medicines written by OECD and published by OECD Publishing. This book was released on 2018-11-29 with total page 192 pages. Available in PDF, EPUB and Kindle. Book excerpt: This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.
